Activation of prostaglandin EP receptors by lubiprostone in rat and human stomach and colon.
about
E-type prostanoid receptor 4 (EP4) in disease and therapyTreatment for constipation: new and old pharmacological strategiesClC-2 regulation of intestinal barrier function: Translation of basic science to therapeutic targetLubiprostone stimulates duodenal bicarbonate secretion in ratsAdenosine A(1) and prostaglandin E receptor 3 receptors mediate global airway contraction after local epithelial injury.Lubiprostone improves intestinal permeability in humans, a novel therapy for the leaky gut: A prospective randomized pilot study in healthy volunteers.Emerging Pharmacologic Therapies for Constipation-predominant Irritable Bowel Syndrome and Chronic Constipation.Lubiprostone ameliorates the cystic fibrosis mouse intestinal phenotype.Review article: new receptor targets for medical therapy in irritable bowel syndromeLubiprostone reverses the inhibitory action of morphine on intestinal secretion in guinea pig and mouse.Effects of lubiprostone on pacemaker activity of interstitial cells of cajal from the mouse colon.American Gastroenterological Association technical review on constipation.Lubiprostone: evaluation of the newest medication for the treatment of adult women with constipation-predominant irritable bowel syndromeChallenges and prospects for pharmacotherapy in functional gastrointestinal disorders.Treatment of Chronic Constipation: Prescription Medications and Surgical Therapies.Prokinetic effects of large-dose lubiprostone on gastrointestinal transit in dogs and its mechanismsA comparison of linaclotide and lubiprostone dosing regimens on ion transport responses in human colonic mucosaSevere defects in absorptive ion transport in distal colons of mice that lack ClC-2 channels.Advancing treatment options for chronic idiopathic constipation.Prophylactic and therapeutic benefits of COX-2 inhibitor on motility dysfunction in bowel obstruction: roles of PGE₂ and EP receptorsObligatory Role of EP1 Receptors in the Increase in Cerebral Blood Flow Produced by Hypercapnia in the Mice.Prostaglandin E2 EP3 receptor regulates cyclooxygenase-2 expression in the kidney.Lubiprostone activates CFTR, but not ClC-2, via the prostaglandin receptor (EP(4)).Lubiprostone induced ischemic colitis.Lubiprostone reverses the inhibitory action of morphine on mucosal secretion in human small intestineEffect of a chloride channel activator, lubiprostone, on colonic sensory and motor functions in healthy subjects.Stimulation of mucosal secretion by lubiprostone (SPI-0211) in guinea pig small intestine and colon.Lubiprostone stimulates secretion from tracheal submucosal glands of sheep, pigs, and humans.Behavioural and new pharmacological treatments for constipation: getting the balance rightLubiprostone for the treatment of opioid-induced bowel dysfunction.Pharmacology of the new treatments for lower gastrointestinal motility disorders and irritable bowel syndrome.New treatment options for chronic constipation: mechanisms, efficacy and safety.Safety evaluation of lubiprostone in the treatment of constipation and irritable bowel syndrome.Cell biology and physiology of CLC chloride channels and transporters.Emerging treatments for chronic constipation.Lubiprostone: pharmacokinetic, pharmacodynamic, safety and regulatory aspects in the treatment of constipation-predominant irritable bowel syndrome.New Options in Constipation Management.PGE2 upregulates renin through E-prostanoid receptor 1 via PKC/cAMP/CREB pathway in M-1 Cells.Constipation: Pathophysiology and Current Therapeutic Approaches.Lubiprostone activates Cl- secretion via cAMP signaling and increases membrane CFTR in the human colon carcinoma cell line, T84.
P2860
Q26851156-5501613B-BD0A-45EA-98BF-7A2296924F2CQ27027346-F710AA21-784B-40B5-AE4E-432A63312783Q28066092-B7A92BDF-4A1F-4214-895D-F06DCAA76A6DQ28572915-2AC8F593-1915-41FF-A94A-8C0F511D4A88Q30537881-4867950D-583E-4A40-9D8E-34DC079EDC7FQ33565654-E3F4B1DC-3F05-4DEE-9DA9-0199BD44BA35Q33586854-BC2E7873-E594-47EC-A796-B3A2418443FDQ33693282-F4FF318B-4347-4F3F-BAA2-E96DA5DAEBBCQ33959307-E419ED34-7E16-4A3A-B512-6B4A3AB7E0B1Q34028142-A97C1D4F-FF8E-42C0-AC0A-8CC42DCCBDCCQ34097910-069A5FD5-6B9C-4A9E-B53E-D267E3F4B62CQ34319119-00FEE6D6-43A4-4EB9-866E-B95A862FE5FDQ34345704-9A8AD885-4094-4EAD-9E59-03A859CD40AAQ34409219-5D277804-49A7-4B7E-806E-D5B71D39927FQ34522966-DC052220-478B-453F-BAD3-2F306DDEDA7EQ35662982-7E473480-F432-4E5C-90A8-50F015745C9AQ35664952-84C808E5-A1E6-4464-9554-32A5F0FBD4CEQ35705381-BC2AC7F9-633C-463C-ACAE-C95877D2A0BAQ35858864-95563308-35BE-4BCD-826C-91A750F86A9DQ35925166-DCAE4ABE-8C75-4422-A461-0EFAC805F485Q36140865-E5EA947C-8EFC-46B4-B427-899DF4F126D8Q36208907-4D061D12-A3E9-4212-99A6-E9F58D8BD630Q36371798-8C8F0DCC-A020-49E1-9125-C97E878EB14BQ36541185-74D3F1F1-1742-4557-B5C7-0E31EA6501FAQ36590527-89AA7D76-F915-4722-958D-FC20D2FC3CA4Q37100282-72AA8C50-F6EC-4F74-BD29-8D717AB9D9AAQ37162424-DD8B06C7-811B-4DBA-BB6F-494706615192Q37190237-ACDC5816-D181-4CD4-8999-0C2D49A75F9DQ37783838-78A8C872-E4A4-4671-AC26-84953CFCEDC4Q37850804-F92C7AB3-65BA-4E46-BAEE-1E35E54957F5Q37954521-ED298D85-27A5-434F-90DD-5CB6A48FBD11Q37960501-1F149CDD-AE8E-40D5-A702-D74BAC076319Q38029718-230F5F85-7E30-4D86-A698-FFECEDCB6B90Q38110745-7E98EDA5-2A7E-46CB-B93F-42BF632653AFQ38129960-55062F95-B02A-40E8-AC82-57BAC1DA3EC3Q38175457-8BB6CA41-D66B-4722-BCD9-DBFFD4FBC952Q38602701-316CC074-7F48-45A6-8194-A6DEABF2F4AFQ38697488-514558F5-62B0-4841-A56F-8EAC2AFE6AC3Q38759113-1121DA18-7AAD-4E24-8DDA-B3F6951AE4EEQ39622609-AABFB088-CEBB-4115-B1EB-5F6292AAC321
P2860
Activation of prostaglandin EP receptors by lubiprostone in rat and human stomach and colon.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Activation of prostaglandin EP ...... t and human stomach and colon.
@ast
Activation of prostaglandin EP ...... t and human stomach and colon.
@en
type
label
Activation of prostaglandin EP ...... t and human stomach and colon.
@ast
Activation of prostaglandin EP ...... t and human stomach and colon.
@en
prefLabel
Activation of prostaglandin EP ...... t and human stomach and colon.
@ast
Activation of prostaglandin EP ...... t and human stomach and colon.
@en
P2093
P2860
P356
P1476
Activation of prostaglandin EP ...... at and human stomach and colon
@en
P2093
A K Bassil
E M Jarvie
E Z H Sung
R A Borman
R J McArthur-Wilson
R Thangiah
P2860
P304
P356
10.1038/BJP.2008.84
P407
P577
2008-03-10T00:00:00Z